MAI Capital Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

MAI Capital Management’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-401	Closed	-$1.36K	–	4164
2025 Q2	$1.36K	Hold	401	–	–	﹤0.01%	3535
2025 Q1	$1.13K	Sell	401 -750	-65%	-$2.21K	﹤0.01%	3097
2024 Q4	$3.09K	Buy	+1,151	New	+$3.75K	﹤0.01%	2926

Other funds holding CSCI

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

MAI Capital Management's CSCI Position: Q3 2025 in Review

MAI Capital Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 401 shares — an estimated $1.36K sold.

MAI Capital Management first reported a position in CSCI in Q4 2024 and held it in 3 quarters. The position peaked at $3.09K in Q4 2024. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.

MAI Capital Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
MAI Capital Management sold 401 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $1.36K.
MAI Capital Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2024 and held it in 3 quarters.
MAI Capital Management's COSCIENS Biopharma Inc. Common Stock position peaked at $3.09K in Q4 2024.
2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.

Based on MAI Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.